Literature DB >> 13446382

Prolongation of chloral hydrate sleeping time by 5-hydroxytryptamine and by certain other drugs.

F N FASTIER, R N SPEDEN, H WAAL.   

Abstract

Various drugs have been tested for a capacity to prolong the hypnotic effect of chloral hydrate in mice. Amongst the compounds which, when injected subcutaneously in substantial amount shortly before the chloral hydrate (250 mg./kg. intraperitoneally), increased sleeping time significantly were adrenaline, noradrenaline, phenylephrine, methoxamine, 5-hydroxytryptamine (serotonin), histamine, ergotamine, yohimbine, and atropine. The ability of these drugs to prolong chloral hydrate sleeping time could not be related to any common circulatory property, but most of the active drugs are known to lower body temperature under comparable conditions. It was found that mice which have been pre-treated with 5-hydroxytryptamine or adrenaline suffer a much greater fall of body temperature when chloral hydrate is given subsequently than do mice which have been given chloral hydrate alone. It is suggested that some, at least, of the drugs which prolong the effects of hypnotics do so by virtue of a hypothermic action.

Entities:  

Keywords:  CHLORAL HYDRATE/effects; HYPNOTICS AND SEDATIVES/effects; HYPOTHERMIA; SEROTONIN/effects

Mesh:

Substances:

Year:  1957        PMID: 13446382      PMCID: PMC1509660          DOI: 10.1111/j.1476-5381.1957.tb00129.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  15 in total

1.  Some factors influencing distribution, metabolism and action of barbiturates; a review.

Authors:  R K RICHARDS; J D TAYLOR
Journal:  Anesthesiology       Date:  1956-05       Impact factor: 7.892

2.  Assessment of depressor activity and mydriatic activity of hexamethonium analogues.

Authors:  J G BLACKMAN; F N FASTIER; C M PATEL; L C WONG
Journal:  Br J Pharmacol Chemother       Date:  1956-09

3.  Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.

Authors:  G C SALMOIRAGHI; L SOLLERO; I H PAGE
Journal:  J Pharmacol Exp Ther       Date:  1956-06       Impact factor: 4.030

4.  [5-Hydroxytryptamine and barbiturates].

Authors:  P FORNAROLI; M KOLLER
Journal:  Farmaco Sci       Date:  1954

5.  Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system.

Authors:  P A SHORE; S L SILVER; B B BRODIE
Journal:  Experientia       Date:  1955-07-15

6.  Antagonism of cortisone to body temperature reducing effect of histamine.

Authors:  L S KIND
Journal:  Proc Soc Exp Biol Med       Date:  1954-02

7.  [Effect of pharmaceuticals on underpressure tolerance].

Authors:  W FLACKE; G MULKE; R SCHULZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1953

8.  Urinary excretion of d-tubocurarine in man.

Authors:  W KALOW
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

9.  The methonium.

Authors:  W D M PATON; E ZAIMIS
Journal:  Pharmacol Rev       Date:  1952-09       Impact factor: 25.468

10.  The influence of antihistamines on the effect of histamine upon body temperature and oxygen consumption in mice and rats.

Authors:  M FABINYI-SZEBEHELY; J SZEBEHELY
Journal:  Acta Physiol Scand       Date:  1952
View more
  4 in total

1.  [EXPERIMENTAL AND BIOMETRIC STUDIES ON THE RELATION BETWEEN BRAIN CONCENTRATION, ELIMINATION RATE, SLEEP DURATION AND BODY TEMPERATURE IN HEXOBARBITAL ANESTHESIA IN MICE].

Authors:  D WINNE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-29

2.  Serotonin and the carcinoid syndrome.

Authors:  W P JONES
Journal:  Can Anaesth Soc J       Date:  1959-04

3.  Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system.

Authors:  R Laverty; K M Taylor
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

4.  Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine.

Authors:  F N FASTIER; M A McDOWALL; H WAAL
Journal:  Br J Pharmacol Chemother       Date:  1959-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.